Document is current
Any future updates will be listed below
-
Authors
Zhou, Libo
Rubin, Lee E.
Liu, Chuanju
Chen, Yupeng
-
Funding
Funding for this research was provided by:
DHHS/NIH/NIAMS (7R01AR072024, 7R03AR069383)
National Science Foundation (1905785)
- License Information
-
More Information
Article History
Received: 23 July 2019
Revised: 27 December 2019
Accepted: 21 January 2020
First Online: 29 January 2020
Compliance with Ethical Standards
:
: Dr. Yupeng Chen is co-founder of NanoDe Therapeutics.
